Company logo

CDXS - Codexis, Inc.

NASDAQ -> Healthcare -> Biotechnology
Redwood City, United States
Type: Equity

CDXS price evolution
CDXS
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Current assets
Cash $66.7 $76.63 $94.15 $104.88
Short term investments -$0.07 -$0.13 -$0.13 -$0.16
Net receivables $19.18 $17.29 $19.5 $17.73
Inventory $2.69 $2.31 $2.05 $2
Total current assets $93.47 $103.01 $120.04 $129.95
Long term investments $9.7 $18.01 $21.38 $21.31
Property, plant & equipment $28.62 $29.18 $60.07 $61.62
Goodwill & intangible assets $2.46 $2.46 $3.24 $3.24
Total noncurrent assets $43.09 $51.44 $86.72 $88.11
Total investments $9.63 $17.88 $21.25 $21.15
Total assets $136.56 $154.46 $206.76 $218.07
Current liabilities
Accounts payable $5.95 $3.1 $4.04 $4.49
Deferred revenue $10.76 $19.34 $20.64 $28.88
Short long term debt $3.78 $6.76 $5.63 $5.49
Total current liabilities $35.83 $38.41 $35.74 $38.31
Long term debt $12.24 $13.21 $35.38 $36.84
Total noncurrent liabilities $14.12 $24.53 $46.89 $53.74
Total debt $16.02 $19.98 $41.01 $42.34
Total liabilities $49.95 $62.95 $82.63 $92.05
Shareholders' equity
Retained earnings -$497.53 -$490.34 -$455.43 -$443.91
Other shareholder equity
Total shareholder equity $86.61 $91.51 $124.13 $126.02
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $66.7 $116.03 $118.89 $150.82
Short term investments -$0.07 -$0.16 -$0.42 $0.93
Net receivables $19.18 $40.87 $33.51 $24.84
Inventory $2.69 $2.03 $1.16 $0.96
Total current assets $93.47 $162.89 $161.89 $184.42
Long term investments $9.7 $20.51 $14 $1.45
Property, plant & equipment $28.62 $61.88 $65.46 $31.18
Goodwill & intangible assets $2.46 $3.24 $3.24 $3.24
Total noncurrent assets $43.09 $87.5 $84.5 $37.22
Total investments $9.63 $20.35 $13.59 $2.38
Total assets $136.56 $250.39 $246.38 $221.65
Current liabilities
Accounts payable $5.95 $3.25 $3 $2.97
Deferred revenue $10.76 $30.61 $6.33 $4.79
Short long term debt $3.78 $5.36 $4.09 $2.63
Total current liabilities $35.83 $49.07 $33.37 $24.98
Long term debt $12.24 $38.28 $43.56 $22.32
Total noncurrent liabilities $14.12 $56.53 $48.62 $26.56
Total debt $16.02 $43.64 $47.65 $24.95
Total liabilities $49.95 $105.6 $81.99 $51.54
Shareholders' equity
Retained earnings -$497.53 -$421.29 -$387.7 -$366.42
Other shareholder equity
Total shareholder equity $86.61 $144.8 $164.39 $170.1
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Revenue
Total revenue $26.56 $9.28 $21.32 $12.98
Cost of revenue $2.86 $2.25 $3.18 $4.52
Gross Profit $23.7 $7.03 $18.14 $8.46
Operating activities
Research & development $11.23 $13.66 $17.33 $16.66
Selling, general & administrative $12.18 $12.3 $13.37 $15.4
Total operating expenses $23.42 $39.09 $30.77 $32.13
Operating income $0.28 -$32.06 -$12.63 -$23.66
Income from continuing operations
EBIT -$7.16 -$34.9 -$11.51 -$22.6
Income tax expense $0.04 $0.01 $0.01 $0.02
Interest expense
Net income
Net income -$7.19 -$34.91 -$11.52 -$22.62
Income (for common shares) -$7.19 -$34.91 -$11.52 -$22.62
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $70.14 $138.59 $104.75 $69.06
Cost of revenue $12.81 $38.03 $22.21 $13.74
Gross Profit $57.33 $100.56 $82.55 $55.31
Operating activities
Research & development $58.88 $80.1 $55.92 $44.19
Selling, general & administrative $53.25 $52.17 $49.32 $35.05
Total operating expenses $125.4 $135.44 $105.24 $79.23
Operating income -$68.07 -$34.88 -$22.7 -$23.92
Income from continuing operations
EBIT -$76.17 -$33.32 -$21.09 -$23.67
Income tax expense $0.07 $0.28 $0.19 $0.34
Interest expense
Net income
Net income -$76.24 -$33.59 -$21.28 -$24.01
Income (for common shares) -$76.24 -$33.59 -$21.28 -$24.01
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income -$7.19 -$34.91 -$11.52 -$22.62
Operating activities
Depreciation $1.97 $2.49 $2.75 $2.71
Business acquisitions & disposals -$1.19
Stock-based compensation $2.16 $2.28 $2.72 $2.81
Total cash flows from operations -$11.04 -$16.3 -$16.09 -$9.21
Investing activities
Capital expenditures $1.1 -$0.67 -$1.57 -$2.53
Investments $1.19 -$0.44 -$0.75
Total cash flows from investing $1.1 -$1.11 -$1.57 -$3.28
Financing activities
Dividends paid
Sale and purchase of stock -$0.11 $6.92 $1.76
Net borrowings
Total cash flows from financing -$0.11 $6.92 $1.35
Effect of exchange rate
Change in cash and equivalents -$9.93 -$17.52 -$10.73 -$11.14
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income -$76.24 -$33.59 -$21.28 -$24.01
Operating activities
Depreciation $9.92 $10.25 $5.95 $4.55
Business acquisitions & disposals -$1.19 -$5.3 -$7.63
Stock-based compensation $9.97 $14.53 $11.59 $7.73
Total cash flows from operations -$52.64 $11.28 -$14.27 -$16.46
Investing activities
Capital expenditures -$3.67 -$8.28 -$13.79 -$3.75
Investments -$2
Total cash flows from investing -$4.86 -$13.58 -$21.42 -$5.75
Financing activities
Dividends paid
Sale and purchase of stock $8.57 $0.91 $4.97 $87.57
Net borrowings -$0.06
Total cash flows from financing $8.17 -$0.57 $3.77 $80.81
Effect of exchange rate
Change in cash and equivalents -$49.33 -$2.87 -$31.92 $58.6
Fundamentals
Market cap $245.37M
Enterprise value $194.69M
Shares outstanding 69.91M
Revenue $70.14M
EBITDA -$66.25M
EBIT -$76.17M
Net Income -$76.24M
Revenue Q/Q -12.56%
Revenue Y/Y N/A
P/E ratio -3.22
EV/Sales 2.78
EV/EBITDA -2.94
EV/EBIT -2.56
P/S ratio 3.50
P/B ratio 2.83
Book/Share 1.24
Cash/Share 0.95
EPS -$1.09
ROA -42.60%
ROE -71.21%
Debt/Equity 0.58
Net debt/EBITDA 0.25
Current ratio 2.61
Quick ratio 2.53